Who is sponsoring NCT05370118?

NCT05370118 is sponsored by Creighton University.

What drugs are being tested in NCT05370118?

Interventions in NCT05370118: Telerehabilitation physical activity behavioral (TPAB) intervention.

What condition does NCT05370118 study?

NCT05370118 studies Mild Cognitive Impairment, Caregiver Burnout.

Is NCT05370118 still recruiting?

NCT05370118 is currently completed.

Are results published for NCT05370118?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2026-06-10 · How we verify

NCT05370118

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Physical Activity With Cognitive Impairment

Completed NA Results posted

What this trial tests

NA trial testing Telerehabilitation physical activity behavioral (TPAB) intervention in Mild Cognitive Impairment in 16 participants. Completed in 30 June 2025.

Timeline

1 February 2023

30 June 2025

Quick facts

Lead sponsor	Creighton University
Phase	NA
Status	Completed
Enrollment	16
Start date	1 February 2023
Estimated completion	30 June 2025

Drugs / interventions tested

Telerehabilitation physical activity behavioral (TPAB) intervention

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Caregiver Burnout — all drugs for Caregiver Burnout →

Sponsor

Creighton University

Who can join

Eligibility, any sex, with Mild Cognitive Impairment or Caregiver Burnout.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other Creighton University trials

Trials by the same sponsor.

NCT06732440 — Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation · NA · recruiting
NCT07171255 — Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska · NA · recruiting
NCT06853275 — The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia · NA · recruiting
NCT06976060 — High-Intensity Interval Training in a Community Gym · NA · completed
NCT07237581 — Cognitive Behavioral Based Physical Therapy for Patients With Chronic Ankle Instability · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05370118 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Creighton University
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05370118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing